Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation
Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular atrial fibrillation (AF) who were hospitalized in the cardiology department of a multidisciplinary hospital.Material and methods. A retrospective one-time study of medical records of 765 patients with non-...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2019-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1858 |
| _version_ | 1797232152005312512 |
|---|---|
| author | V. I. Petrov O. V. Shatalova A. S. Gerasimenko V. S. Gorbatenko |
| author_facet | V. I. Petrov O. V. Shatalova A. S. Gerasimenko V. S. Gorbatenko |
| author_sort | V. I. Petrov |
| collection | DOAJ |
| description | Aim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular atrial fibrillation (AF) who were hospitalized in the cardiology department of a multidisciplinary hospital.Material and methods. A retrospective one-time study of medical records of 765 patients with non-valvular AF treated in the cardiology department of a multidisciplinary hospital in 2012 and 2016 was performed.Results. All patients were stratified in three groups depending on the CHA2DS2-VASc score. The frequency of prescribing antithrombotic agents was evaluated in each group. A low risk of thromboembolic complications was found in 1% (n=3) of patients in 2012 and 0.6% (n=3) in 2016. All these patients received antithrombotic agents. CHA2DS2-VASc=1 was found in 6% (n=15) of patients with AF in 2012 and in 3.4% (n=17) in 2016. A significant number of patients in this group received anticoagulant therapy with vitamin K antagonists (warfarin) or with direct oral anticoagulants. A high risk of thromboembolic complications (CHA2DS2-VASc≥2) was found in 93% of patient (n=245) in 2012 and in 96% (n=482) in 2016. Anticoagulant therapy was prescribed in 70.2% (n=172) patients with high risk in 2012 and 80% (n=387) in 2016. However, some patients with high risk of thromboembolic complications did not have the necessary therapy.Conclusion. Positive changes in the structure and frequency of prescribing anticoagulant drugs in patients with AF and a high risk of thromboembolic complications were found during the years studied. |
| first_indexed | 2024-03-08T14:01:58Z |
| format | Article |
| id | doaj.art-5aacaab3d4e542849d631bb1729a688c |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T15:55:43Z |
| publishDate | 2019-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-5aacaab3d4e542849d631bb1729a688c2024-04-01T07:43:37ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-03-01151495310.20996/1819-6446-2019-15-1-49-531573Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial FibrillationV. I. Petrov0O. V. Shatalova1A. S. Gerasimenko2V. S. Gorbatenko3Volgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityVolgograd State Medical UniversityAim. To study the frequency of prescribing antithrombotic agents in patients with non-valvular atrial fibrillation (AF) who were hospitalized in the cardiology department of a multidisciplinary hospital.Material and methods. A retrospective one-time study of medical records of 765 patients with non-valvular AF treated in the cardiology department of a multidisciplinary hospital in 2012 and 2016 was performed.Results. All patients were stratified in three groups depending on the CHA2DS2-VASc score. The frequency of prescribing antithrombotic agents was evaluated in each group. A low risk of thromboembolic complications was found in 1% (n=3) of patients in 2012 and 0.6% (n=3) in 2016. All these patients received antithrombotic agents. CHA2DS2-VASc=1 was found in 6% (n=15) of patients with AF in 2012 and in 3.4% (n=17) in 2016. A significant number of patients in this group received anticoagulant therapy with vitamin K antagonists (warfarin) or with direct oral anticoagulants. A high risk of thromboembolic complications (CHA2DS2-VASc≥2) was found in 93% of patient (n=245) in 2012 and in 96% (n=482) in 2016. Anticoagulant therapy was prescribed in 70.2% (n=172) patients with high risk in 2012 and 80% (n=387) in 2016. However, some patients with high risk of thromboembolic complications did not have the necessary therapy.Conclusion. Positive changes in the structure and frequency of prescribing anticoagulant drugs in patients with AF and a high risk of thromboembolic complications were found during the years studied.https://www.rpcardio.online/jour/article/view/1858atrial fibrillationthromboembolic complicationspharmacoepidemiologic studyantithrombotic therapy |
| spellingShingle | V. I. Petrov O. V. Shatalova A. S. Gerasimenko V. S. Gorbatenko Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation Рациональная фармакотерапия в кардиологии atrial fibrillation thromboembolic complications pharmacoepidemiologic study antithrombotic therapy |
| title | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation |
| title_full | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation |
| title_fullStr | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation |
| title_full_unstemmed | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation |
| title_short | Comparative Analysis of Antithrombotic Therapy in In-Patients with Atrial Fibrillation |
| title_sort | comparative analysis of antithrombotic therapy in in patients with atrial fibrillation |
| topic | atrial fibrillation thromboembolic complications pharmacoepidemiologic study antithrombotic therapy |
| url | https://www.rpcardio.online/jour/article/view/1858 |
| work_keys_str_mv | AT vipetrov comparativeanalysisofantithrombotictherapyininpatientswithatrialfibrillation AT ovshatalova comparativeanalysisofantithrombotictherapyininpatientswithatrialfibrillation AT asgerasimenko comparativeanalysisofantithrombotictherapyininpatientswithatrialfibrillation AT vsgorbatenko comparativeanalysisofantithrombotictherapyininpatientswithatrialfibrillation |